News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Endovasc Inc. (EVSC) Announces Completion Of Liprostin Manufacturing For Phase IIIa Trial


9/6/2006 11:01:21 AM

HOUSTON--(BUSINESS WIRE)--Sept. 6, 2006--ENDOVASC INC. (OTCBB:EVSC), today announced that PYRAMID Laboratories, Inc. has completed the cGMP manufacturing of Liprostin for the Company's proposed phase IIIa clinical trial for patients suffering from Intermittent Claudication.

Read at BioSpace.com

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES